CaV3.2 T-type calcium channels contribute to CGRP- induced allodynia in a rodent model of experimental migraine
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
CaV3.2 T-type calcium channels contribute to CGRP- induced allodynia in a rodent model of experimental migraine ; volume:25 ; number:1 ; day:18 ; month:12 ; year:2024 ; pages:1-11 ; date:12.2024
The journal of headache and pain ; 25, Heft 1 (18.12.2024), 1-11, 12.2024
- Urheber
-
Baggio, Darciane F.
Gambeta, Eder
Souza, Ivana A.
Huang, Sun
Zamponi, Gerald W.
Chichorro, Juliana G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-024-01921-0
- URN
-
urn:nbn:de:101:1-2503010636486.364688441180
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baggio, Darciane F.
- Gambeta, Eder
- Souza, Ivana A.
- Huang, Sun
- Zamponi, Gerald W.
- Chichorro, Juliana G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
CGRP and migraine: neurogenic inflammation revisited
Acetaldehyde via CGRP receptor and TRPA1 in Schwann cells mediates ethanol-evoked periorbital mechanical allodynia in mice: relevance for migraine
Prevalence and characteristics of cutaneous allodynia in probable migraine
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
CGRP-targeted medication in chronic migraine - systematic review
TRPM8 genetic variant is associated with chronic migraine and allodynia
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Serum CGRP in migraine patients using erenumab as preventive treatment
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
CGRP and migraine: neurogenic inflammation revisited
Acetaldehyde via CGRP receptor and TRPA1 in Schwann cells mediates ethanol-evoked periorbital mechanical allodynia in mice: relevance for migraine
Prevalence and characteristics of cutaneous allodynia in probable migraine
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
CGRP-targeted medication in chronic migraine - systematic review
TRPM8 genetic variant is associated with chronic migraine and allodynia
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Serum CGRP in migraine patients using erenumab as preventive treatment
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
CGRP and migraine: neurogenic inflammation revisited
Acetaldehyde via CGRP receptor and TRPA1 in Schwann cells mediates ethanol-evoked periorbital mechanical allodynia in mice: relevance for migraine
Prevalence and characteristics of cutaneous allodynia in probable migraine
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
CGRP-targeted medication in chronic migraine - systematic review
TRPM8 genetic variant is associated with chronic migraine and allodynia
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Serum CGRP in migraine patients using erenumab as preventive treatment